ALNY presentation at Adams Harkness: Very informative 30-minute talk, and it’s tangentially relevant to GENR because ALNY plans to launch a phase-1 AMD trial with partner Merck in 2005: <A HREF="http://phx.corporate-ir.net/phoenix.zhtml?c=148005&p=IROL-eventDetails&EventId=925465" target="_blank">http://phx.corporate-ir.net/phoenix.zhtml?c=148005&p=IROL-eventDetails&EventId=925465</A>